AbbVie (ABBV): 98.0% of its 52-week range
On 2026-10-14, AbbVie (ABBV) closed at 283.48 USD, up 3.32% on the day. At the 2026-10-14 close, AbbVie (ABBV) traded at 98.0% of its 52-week range. At the 2026-10-14 close, AbbVie (ABBV) had an RSI(14) of 69.68, in the 90th percentile of its history since 2013. Its 20-day return of +7.99% is in the 84th percentile of its history since 2013. The RSI(14) of AbbVie (ABBV) last entered the overbought zone 5 days ago (2026-10-09) and the oversold zone 209 days ago (2026-03-19). It is trading above its 20-, 50- and 200-day moving averages. At the 2026-10-14 close, the 20/50/200-day moving averages of AbbVie (ABBV) were 267.89 / 260.88 / 233.4 USD, with price +5.82% / +8.66% / +21.45% against them. Ranked from highest to lowest, its moving averages are the 20-day, 50-day and 200-day. At the 2026-10-14 close, the 52-week range of AbbVie (ABBV) was 190.75–285.4 USD; it closed 0.67% below the high (0.3× its typical daily range) and 48.61% above the low (14.3× its typical daily range). The high was set today (2026-10-14) and the low 168 days ago (2026-04-29). At the 2026-10-14 close, AbbVie (ABBV) was 0.67% below its all-time intraday high of 285.4 USD, set today (2026-10-14). Its 20-day volatility is 1.209% daily, in the 36th percentile of its history since 2013. Its daily realised volatility is 2.122% over 5 days, 1.209% over 20 days, 1.382% over 60 days and 1.628% over 120 days. Annualised, these are 33.7%, 19.2%, 21.9% and 25.8% respectively. Its 14-day average true range (ATR) is 6.47 USD, 2.28% of price. It has returned +4.47% (90th percentile since 2013) over 5 days, +8.37% (94th) over 10 days, +7.99% (84th) over 20 days, +10.69% (72nd) over 60 days, +41.07% (97th) over 120 days and +23.09% (64th) over 252 days. Against the S&P 500, its weekly returns show a beta of -0.71 and a correlation of -0.30 over 52 weeks; over 26 weeks, a beta of -1.77 and a correlation of -0.54. Relative to the S&P 500, it has returned +5.53% (5-day), +7.49% (10-day), +5.78% (20-day), +7.90% (60-day) and +7.10% (252-day). Its weekly-return correlation with changes in the US 10-year TIPS real yield is -0.10 over 52 weeks and -0.02 over 26 weeks. Next earnings are scheduled for 2026-10-30.
Figures reflect the official regular-session close for 2026-10-14.
=== ABBVIE (ABBV) (USD) ===
price & change (as of 2026-10-14, prior 2026-10-13)
close 283.48
change +9.12 (+3.324%)
vs market S&P 500 -1.11% · Nasdaq 100 -1.97% (same day)
listing Exchange: NYSE, Currency: USD
range (as of 2026-10-14)
range 9.43
close pos 79.6% of range
moving averages (as of 2026-10-14)
20d MA 267.89 price above by +5.82%
50d MA 260.88 price above by +8.66%
200d MA 233.40 price above by +21.45%
200d MA slope +1.82% over 20 sessions (rising)
price > all MAs
stack: 20d > 50d > 200d
20d MA last crossed above 50d MA: 2026-05-27 (140d ago)
20d MA last crossed above 200d MA: 2026-06-22 (114d ago)
50d MA last crossed above 200d MA: 2026-07-09 (97d ago)
volatility (as of 2026-10-14)
20d stdev 1.209% daily ≈ 19.2% annualised (×√252) (36th pct of own history, since 2013 (3447 obs))
5d vol 2.122% daily ≈ 33.7% annualised (×√252) (85th pct of own history, since 2013 (3462 obs))
60d vol 1.382% daily ≈ 21.9% annualised (×√252) (39th pct of own history, since 2013 (3407 obs))
120d vol 1.628% daily ≈ 25.8% annualised (×√252) (59th pct of own history, since 2013 (3347 obs))
vs easing-2024 avg 0.75× (1.209% vs 1.604% era avg)
ATR (as of 2026-10-14)
ATR(14) 6.47
ATR% 2.28% (62nd pct of own history, since 2013 (3453 obs))
range/ATR 145.8%
relative volume (as of 2026-10-14)
RVOL 1.21x (today vs prior 20-day average, excl. today)
pctile 80th pct of own history, since 2013 (3447 obs)
avg vol 63d 4,816,817 (≈3-month average daily share volume)
52-week range (as of 2026-10-14)
high 285.40 (-0.67% from high) [2026-10-14, 0d ago]
low 190.75 (+48.61% from low) [2026-04-29, 168d ago]
drawdown -0.67% from all-time intraday high, 0d ago (2026-10-14)
max drawdown (10-year, close-basis) -48.88% (2018-01-26 123.21 -> 2019-08-15 62.98, 566d peak-to-trough); recovered 2021-12-09 (847d after trough)
momentum (as of 2026-10-14)
RSI(14) 69.68 (90th pct of own history, since 2013 (3453 obs))
last overbought 5d ago (2026-10-09)
last oversold 209d ago (2026-03-19)
MACD (as of 2026-10-14)
MACD(12,26,9) +5.05 (above signal) signal +3.52 hist +1.53
returns (as of 2026-10-14)
5d return +4.47% from 271.36 on 2026-10-07 (90th pct of own history, since 2013 (3462 obs))
10d return +8.37% from 261.59 on 2026-09-30 (94th pct of own history, since 2013 (3457 obs))
20d return +7.99% from 262.51 on 2026-09-16 (84th pct of own history, since 2013 (3447 obs))
60d return +10.69% from 256.10 on 2026-07-21 (72nd pct of own history, since 2013 (3407 obs))
120d return +41.07% from 200.95 on 2026-04-23 (97th pct of own history, since 2013 (3347 obs))
252d return +23.09% from 230.30 on 2025-10-13 (64th pct of own history, since 2013 (3215 obs))
YTD return +24.07% from 228.49 on 2025-12-31
volatility by rate-era
ZIRP (2009–2015) 1.73% (from 2013-01-02)
tightening (2015–2018) 1.75%
ZIRP (2019–2021) 1.77%
tightening (2022–2023) 1.33%
easing (2024– ) 1.60%
real-yield sensitivity (weekly returns vs weekly Δ in 10Y TIPS real yield, DFII10) (as of 2026-10-13)
vs real yield (Δ) -0.02 (26w)
vs real yield (Δ) -0.10 (52w)
S&P 500 market factor (weekly returns) (as of 2026-10-14)
vs S&P 500 beta -1.77 corr -0.54 (26w)
vs S&P 500 beta -0.71 corr -0.30 (52w)
vs S&P 500 +5.53% rel (5d return)
vs S&P 500 +7.49% rel (10d return)
vs S&P 500 +5.78% rel (20d return)
vs S&P 500 +7.90% rel (60d return)
vs S&P 500 +7.10% rel (252d return)
vs Nasdaq 100 beta -1.10 corr -0.64 (26w)
vs Nasdaq 100 beta -0.66 corr -0.44 (52w)
vs Nasdaq 100 +8.26% rel (5d return)
vs Nasdaq 100 +9.83% rel (10d return)
vs Nasdaq 100 +4.55% rel (20d return)
vs Nasdaq 100 +7.87% rel (60d return)
vs Nasdaq 100 +2.01% rel (252d return)
vs XLV (Health Care) beta +1.54 corr +0.84 (26w)
vs XLV (Health Care) beta +1.22 corr +0.71 (52w)
vs XLV +1.42% rel (5d return)
vs XLV +5.08% rel (10d return)
vs XLV +4.30% rel (20d return)
vs XLV +2.14% rel (60d return)
vs XLV +0.54% rel (252d return)
earnings horizon
next earnings 2026-10-30 (16 days)